Searching the RRID Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
Antibody Name
Anti-ArCCK/SKR
RRID:AB_2891354 RRID Copied  
PDF Report How to cite
Maurice Elphick - Queen Mary University of London, UK Cat# ArCCK/SKR, RRID:AB_2891354
Copy Citation Copied
Antibody Information

URL: http://antibodyregistry.org/AB_2891354

Proper Citation: Maurice Elphick - Queen Mary University of London, UK Cat# ArCCK/SKR, RRID:AB_2891354

Target Antigen: CCK/SK-type receptor

Host Organism: guinea pig

Clonality: polyclonal

Comments: "To generate antibodies to ArCCK/SKR, a peptide corresponding to the C-terminal 15 amino-acids of ArCCK/SK-R with addition of an N-terminal reactive lysine residue was synthesized (KPSPTNYTNVSSDSSV, Peptide Protein Research Ltd, Fareham, UK). The peptide was conjugated to porcine thyroglobulin (Sigma-Aldrich, Gillingham, UK) as a carrier protein using 5% glutaraldehyde (Sigma-Aldrich, Gillingham, UK) in phosphate buffer (0.1 M; pH 7.2) and the conjugate was used for immunisation of a guinea pig (56-day protocol; Charles River Biologics, Romans, France). The antigen was emulsified in Freund’s complete adjuvant for primary immunisations (~100 nmol antigen peptide) and in Freund’s incomplete adjuvant for three booster immunisations (~50 nmol antigen peptide). The presence of antibodies to the antigen peptide in post-immunisation serum samples was assessed using an enzyme-linked immunosorbent assay (ELISA), in comparison with pre-immune serum"

Expand All
Usage and Citation Metrics

We found {{ ctrl2.mentions.all_count }} mentions in open access literature.

We have not found any literature mentions for this resource.

We are searching literature mentions for this resource.

Most recent articles:

{{ mention._source.dc.creators[0].familyName }} {{ mention._source.dc.creators[0].initials }}, et al. ({{ mention._source.dc.publicationYear }}) {{ mention._source.dc.title }} {{ mention._source.dc.publishers[0].name }}, {{ mention._source.dc.publishers[0].volume }}({{ mention._source.dc.publishers[0].issue }}), {{ mention._source.dc.publishers[0].pagination }}. (PMID:{{ mention._id.replace('PMID:', '') }})

Checkfor all resource mentions.

Collaborator Network

A list of researchers who have used the resource and an author search tool

Find mentions based on location


{{ ctrl2.mentions.errors.location }}

A list of researchers who have used the resource and an author search tool. This is available for resources that have literature mentions.

Ratings and Alerts

No rating or validation information has been found for Anti-ArCCK/SKR.

No alerts have been found for Anti-ArCCK/SKR.

Data and Source Information
Authentication Plan

dkNET can assist you in preparing authentication plans for antibodies to comply with the NIH Submission Policy. The information can be used while planning your experiments or submitting grant applications. The authentication plan for antibodies is based on methods suggested in "A proposal for validation of antibodies" (Uhlen M et. al., 2016), the guideline published in the Journal of Comparative Neurology (Saper C, 2005)(2), and the example " Authentication of of Key Biological and/or Chemical Resources "(Bandrowski A). For best practices for authenticating antibodies, check our Authentication Reports services.